LYEL vs RBLX · rev $6.0K vs rev $2.91B
Lyell Immunopharma Inc (LYEL) versus Roblox Corp (RBLX) — a side-by-side from cached financials, not a winner call.
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
Roblox Corp (RBLX) is a electronic gaming & multimedia company listed on US. It is led by David Baszucki.
Latest reported LYEL revenue for 2026-06-30 was $6.0K. Net income was -$68.9M. LYEL currently screens at market cap $143.5M.
Latest reported RBLX revenue for 2026-06-30 was $2.91B. Net income was -$429.0M. RBLX currently screens at market cap $68.27B.
LYEL currently screens at market cap $143.5M. RBLX currently screens at market cap $68.27B.
Not investment advice. Open the LYEL and RBLX stock pages for the full models.
Not investment advice.